/SCPX
SCPX Stock - Scorpius Holdings, Inc.
Healthcare|BiotechnologyOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
49
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.71
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SCPX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.22
52W High$0.80
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $6.24M | $6.99M | $5.98M | $2.11M | $2.95M |
| Gross Profit | $3.05M | $-2,216,416 | $-420,025 | $1.42M | $2.95M |
| Gross Margin | 48.8% | -31.7% | -7.0% | 67.3% | 100.0% |
| Operating Income | $-33,600,261 | $-42,032,172 | $-45,688,738 | $-35,419,039 | $-26,124,362 |
| Net Income | $-32,807,843 | $-45,217,168 | $-43,434,706 | $-35,071,468 | $-26,049,737 |
| Net Margin | -525.5% | -646.4% | -726.2% | -1659.9% | -883.7% |
| EPS | $-13.04 | $-347.20 | $-339.25 | $-281.54 | $-325.98 |
Company Overview
Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies. It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
SCPXBeat Rate
22%
Last 9 quarters
Avg Surprise
-2721.6%
EPS vs Estimate
Beats / Misses
2/7
Last 12 quarters
Latest EPS
$-1.16
Q3 2025
EPS Surprise History
Q3 23
-17.8%
$-0.53vs$-0.45
Q4 23
-8.6%
$-0.38vs$-0.35
Q1 24
+4.5%
$-0.21vs$-0.22
Q2 24
+15.8%
$-32.00vs$-38.00
Q3 24
No data
Q4 24
No data
Q2 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 28, 2026 | — | — | — | — |
Q4 2025 | Nov 12, 2025 | — | — | — | — |
Q3 2025 | Aug 22, 2025 | — | $-1.16 | — | — |
Q2 2025 | Apr 24, 2025 | — | $-3.74 | — | — |
Q4 2024 | Nov 14, 2024 | — | $-1.35 | — | — |
Q3 2024 | Aug 19, 2024 | — | $-26.98 | — | — |
Q2 2024 | May 28, 2024 | $-38.00 | $-32.00 | +15.8% | ✓ BEAT |
Q1 2024 | Mar 7, 2024 | $-0.22 | $-0.21 | +4.5% | ✓ BEAT |
Q4 2023 | Nov 20, 2023 | $-0.35 | $-0.38 | -8.6% | ✗ MISS |
Q3 2023 | Aug 14, 2023 | $-0.45 | $-0.53 | -17.8% | ✗ MISS |
Q1 2023 | Mar 31, 2023 | $-38.00 | $-98.45 | -159.1% | ✗ MISS |
Q4 2022 | Dec 30, 2022 | $-52.00 | $-94.71 | -82.1% | ✗ MISS |
Q3 2022 | Sep 29, 2022 | $-52.00 | $-101.55 | -95.3% | ✗ MISS |
Q2 2022 | Jun 29, 2022 | $-60.00 | $-79.35 | -32.2% | ✗ MISS |
Q1 2022 | Mar 30, 2022 | — | $-63.46 | — | — |
Q4 2021 | Dec 30, 2021 | $-0.44 | $-105.76 | -24119.2% | ✗ MISS |
Q3 2021 | Sep 29, 2021 | — | $-59.14 | — | — |
Q2 2021 | Jun 29, 2021 | — | $-52.06 | — | — |
Q1 2021 | Mar 30, 2021 | — | $-62.25 | — | — |
Frequently Asked Questions about SCPX
What is SCPX's current stock price?
Scorpius Holdings, Inc. (SCPX) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for SCPX?
No analyst price targets are currently available for this stock.
What sector is Scorpius Holdings, Inc. in?
Scorpius Holdings, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is SCPX's market cap?
Scorpius Holdings, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does SCPX pay dividends?
No, Scorpius Holdings, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAMPE
Ampio Pharmaceuticals, Inc.
$0.01
Mkt Cap: $0.0B
BIOAF
Bioasis Technologies Inc.
$0.00
Mkt Cap: $0.0B
BNYN
Banyan Corp.
$0.00
Mkt Cap: $0.0B
EMYSF
Easy Technologies Inc.
$0.01
Mkt Cap: $0.0B
GBLX
GB Sciences, Inc.
$0.00
Mkt Cap: $0.0B
GSTC
GlobeStar Therapeutics Corporation
$0.00
Mkt Cap: $0.0B
IRBS
IR Biosciences Holdings Inc.
$0.00
Mkt Cap: $0.0B
NEPTF
Neptune Wellness Solutions Inc.
$0.00
Mkt Cap: $0.0B
RGMP
Regnum Corp.
$0.00
Mkt Cap: $0.0B
VRSYF
VMS Rehab Systems, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to SCPX for comparison